vulva neoplasms and common benign lesions maria horvat, md, facog

31
Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Upload: jaxon-ewell

Post on 28-Mar-2015

225 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VulvaNeoplasms and common benign lesions

Maria Horvat, MD, FACOG

Page 2: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Anatomy of the vulva

Page 3: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Lymphatic drainage of the vulva

Page 4: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Cancer

5% of female genital malignanciesUsually occurs in the 70-80 year old populationHistology is necessary for diagnosisOccurs anywhere on vulvaSurgically stagedMost common type is squamous cellMelanoma is 2nd most common – but still <5% Associated with HPV

Page 5: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Cancer

Spreads by direct extension

Embolizes to lymphatics

Hematogenous dissemination

Page 6: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Risks of vulvar cancer

HPV

Lichen sclerosis

Long history of puritis

Lymph nodes are single most important prognostic factor

Page 7: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Intraepithelial Neoplasms

VIN - preinvasive disease

VIN 1

VIN 2

VIN3

Page 8: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Intraepithelial Neoplasms

VIN 1Abnormal cellular changes

Confined to lower 1/3

Epithelium – no progressive vulvar cancer

Page 9: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Intraepithelial Neoplasms

VIN 2“moderate” 1/3-2/3

Epithelium involved

Page 10: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Intraepithelial Neoplasms

VIN 3“severe” 2/3 – all

If untreated most go on to cancer

If treated 4% go on to cancer

Treat with wide local excision

Page 11: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Cancer In-Situ

All epithelium involved

Page 12: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

New Classification for VIN

Old System New System

VIN 1 Flat condyloma or HPV effect

VIN2,3 VIN, usual type

VIN, warty type

VIN, basaloid type

VIN, mixed (warty/basaloid) type

Differentiated VIN VIN, differentiated type

Page 13: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN 3

Page 14: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN 3

Page 15: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN 3

Page 16: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN - Treatment

Local excision

Local destruction

Page 17: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN

50% asymptomatic

25% hyperpigmented

Typically: raised surface

Page 18: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN – Diagnosis

3% acetic acid

Punch biopsy

Page 19: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Staging of Vulvar Carcinoma

Stage CharacteristicsStage 0 Carcinoma in situ; intraepithelial neoplasia grade III

Stage I Lesion <2 cm; confined to the vulva or perineum; no nodal metastasis

Stage Ia Lesion <2 cm; confined to the vulva or perineum and with stromal invasion <1 mm; no nodal metastasis

Stage Ib Lesion <2 cm; confined to the vulva or perineum and with stromal invasion >1mm; no nodal metastasis

Stage II Tumor >2 cm in greatest dimension; confined to the vulva and/or perineum; no nodal metastasis

Stage III Tumor of any size with adjacent spread to the lower urethra and/or vagina or anus and/or unilateral regional lymph node metastasis

Stage Iva Tumor invasion of any of the following: upper urethra, bladder mucosa, rectal mucosa, and/or pelvic bone and/or bilateral regional node metastases

Stage Ivb Any distant metastasis, including pelvic lymph nodes

Page 20: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG
Page 21: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Cancer – prognostic factors

For nodal involvementSizeDepth of invasionLesion thicknessGradeVascular space involvement

For survivalPositive inguinal nodesPositive pelvic nodes

Page 22: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

VIN - Treatment

Cancer-in-situExcision with at least 1cm margins

topical

Invasive CancerInguinal-femoral lymph nodes

Radical excision

Radiation

Pelvic exenteration

Page 23: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Melanoma

Usually arises from nevi

Blue/black

Ulcerated

RX: wide excision with 2 cm free border

If depth of invasion <1.5mm, 100%survival

Page 24: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Melanoma

Page 25: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Vulvar Melanoma

Page 26: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Pagets Disease of the Vulva

Hyperemic tissue

Cake icing effect

Rx: wide local excision

30% will develop adenocarcinoma of the breast, colon, and rectum

Page 28: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Lichen Sclerosis

Itching

Diagnosed by biopsy

Can eventually become VIN or vulvar cancer

20% hypothyroid

Page 29: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Lichen Sclerosis

Page 30: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Remember!

BIOPSY anything suspicious!

Page 31: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

References

The Female Patient; April 2008

Clinical Gynecology; Bieber

www.Images.MD